Anthony T C Chan

11PUBLICATIONS
49CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMathematical aspects of general relativityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 17, 2026
A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas.

|Apr 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Bhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao

|Feb 03, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122.

Anthony T C Chan, Victor Ho Fun Lee, Ruey-Long Hong

|Oct 08, 2025
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines.

W K Jacky Lam, Brigette B Y Ma, Ann D King

|Sep 21, 2022
Magnetic-field-modulated radiotherapy (MagMRT) in inhomogeneous medium and its potential applications.

Vivien W S Chu, Monica W K Kan, Louis K Y Lee

|Apr 05, 2022
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.

Wai-Tong Ng, Cheuk-Wai Choi, Barton But

Pageof 2

Frequent Collaborators

5 joint publications

Brigette Ma

4 joint publications

Wai Kei Jacky Lam

3 joint publications

Edwin Pun Hui

2 joint publications

Boon Cher Goh